EUR · 2 valued
€424 million
Supplier · public contract awards
GlaxoSmithKline Biologicals SA public contracts.
GlaxoSmithKline Biologicals SA has won 5 public contracts between 2021 and 2022 from 3 public buyers in 3 countries. Its most frequent buyer is Bundesrepublik Deutschland, vertreten durch die Taskforce Impfstoffproduktion im Auftrag des Bundesministeriums für Gesundheit (2 awards). Besides Belgium, it has won contracts in Germany and Italy. Outside TED, published values total €424 million across 2 awards.
5Contracts won
3Public buyers
3Countries
Jun 2022Latest award
Latest contracts won
Framework contract for the production and supply of pandemic influenza vaccine
Awarded by European Commission, Directorate-General Health Emergency Preparedness and Response Authority - Hera · Belgium
28 Jun 2022Awarded
Fornitura Annuale Della Specialità Medicinale Blenrep (belantam Mafodotin) Per le Esigenze Della S.C. Ematologia Dell'azienda Ospedaliera- Universitar
Awarded by Azienda Ospedaliero Universitaria DI Sassari · Italy · €262,319
16 Jun 2022Awarded
Vergabe von Pandemiebereitschaftsverträgen
Awarded by Bundesrepublik Deutschland, vertreten durch die Taskforce Impfstoffproduktion im Auftrag des Bundesministeriums für Gesundheit · Germany
13 Jul 2021Awarded
Contracts won by year
Contracts won by year
from the published recordsPublished value, by currency (feeds other than TED)
From published award records. Suppliers are matched by legal name; a company with a different legal name in another country (a national subsidiary, for example) has its own page. Each currency is shown on its own and never converted. TED values are often framework ceilings, so TED awards show a median contract size, never a total.
Bid with askTender
Bidding against GlaxoSmithKline Biologicals SA?
askTender reads any open tender against your company profile — eligibility, the gaps, and the documents you need — and can prepare the entire bid.
askTender See open tenders